Iradimed (IRMD) Cash from Investing Activities (2013 - 2026)
Iradimed (IRMD) reported Cash from Investing Activities of -$469000.0 for Q1 2026, up 88.03% year-over-year from -$249432.9 in Q1 2025, and down 12.63% quarter-over-quarter from -$416407.0 in Q4 2025.
Iradimed (IRMD) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Iradimed (IRMD) has 14 years of Cash from Investing Activities data on file, last reported at -$469000.0 in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$469000.0, up 88.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.0 million (up 59.42% YoY), and the FY2025 annual result was -$8.4 million, up 4.49% from the prior year.
- Cash from Investing Activities fell to -$469000.0 in Q1 2026 per IRMD's latest filing, from -$416407.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $77561.0 in Q2 2022 and troughed at -$6.6 million in Q1 2023.
- A 5-year average of -$1.6 million and a median of -$556188.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities plunged 1443.94% in 2023, then soared 92.7% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$471676.0 in 2022, then plunged by 34.16% to -$632816.0 in 2023, then sank by 383.07% to -$3.1 million in 2024, then surged by 86.38% to -$416407.0 in 2025, then slipped by 12.63% to -$469000.0 in 2026.
- Business Quant data shows IRMD's Cash from Investing Activities at -$469000.0 in Q1 2026, -$416407.0 in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Iradimed | 1.18 Bn | 1.12 Bn | 16.81 Mn | -469,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -469,000.00 |
| Mar 31, 2026 | -469,000.00 |
| Dec 31, 2025 | -416,407.00 |
| Dec 31, 2025 | -416,407.00 |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -3.06 Mn |
| Dec 31, 2024 | -3.06 Mn |
| Sep 30, 2024 | -4.01 Mn |
| Sep 30, 2024 | -4.01 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -478,803.00 |
| Mar 31, 2024 | -478,803.00 |
| Dec 31, 2023 | -632,816.00 |
| Dec 31, 2023 | -632,816.00 |